These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

284 related items for PubMed ID: 15494722

  • 1. Expression of FAP-1 by human colon adenocarcinoma: implication for resistance against Fas-mediated apoptosis in cancer.
    Yao H, Song E, Chen J, Hamar P.
    Br J Cancer; 2004 Nov 01; 91(9):1718-25. PubMed ID: 15494722
    [Abstract] [Full Text] [Related]

  • 2. Cytokine associated sensitivity of colon carcinoma cells to FasR-mediated cytotoxicity of CTL.
    Chen J, Zhang H, Su F, Min J, Zhang J, Song E.
    Asian J Surg; 2002 Jan 01; 25(1):89-97. PubMed ID: 17585452
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F.
    J Immunol; 1998 Jun 01; 160(11):5669-75. PubMed ID: 9605174
    [Abstract] [Full Text] [Related]

  • 6. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
    Fukazawa T, Fujiwara T, Morimoto Y, Shao J, Nishizaki M, Kadowaki Y, Hizuta A, Owen-Schaub LB, Roth JA, Tanaka N.
    Oncogene; 1999 Apr 01; 18(13):2189-99. PubMed ID: 10327065
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. FAP-1-mediated activation of NF-kappaB induces resistance of head and neck cancer to Fas-induced apoptosis.
    Wieckowski E, Atarashi Y, Stanson J, Sato TA, Whiteside TL.
    J Cell Biochem; 2007 Jan 01; 100(1):16-28. PubMed ID: 16888780
    [Abstract] [Full Text] [Related]

  • 9. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
    Que FG, Phan VA, Phan VH, Celli A, Batts K, LaRusso NF, Gores GJ.
    Hepatology; 1999 Dec 01; 30(6):1398-404. PubMed ID: 10573518
    [Abstract] [Full Text] [Related]

  • 10. Fas-related apoptosis in gastric adenocarcinoma.
    Lim SC.
    Oncol Rep; 2003 Dec 01; 10(1):57-63. PubMed ID: 12469145
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Fas ligand expressed in colon cancer is not associated with increased apoptosis of tumor cells in vivo.
    Houston A, Waldron-Lynch FD, Bennett MW, Roche D, O'Sullivan GC, Shanahan F, O'Connell J.
    Int J Cancer; 2003 Nov 01; 107(2):209-14. PubMed ID: 12949796
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fas ligand expression in primary colon adenocarcinomas: evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer.
    O'Connell J, Bennett MW, O'Sullivan GC, Roche D, Kelly J, Collins JK, Shanahan F.
    J Pathol; 1998 Nov 01; 186(3):240-6. PubMed ID: 10211111
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.